Seasonal Influenza Vaccines and Therapeutics Market Revenue 2024 to 2034
Seasonal Influenza Vaccines and Therapeutics Market Revenue 2024 to 2034
The Seasonal Influenza Vaccines and Therapeutics Market is forecasted to expand from USD 19.98 Bn in 2024 to USD 47.79 Bn by 2034, at a CAGR of 9.11%. Growth is fueled by rising flu prevalence, expanding immunization programs, and advancements in next-gen antiviral therapeutics worldwide.
Report ID: 10327
|
Format: Databook
|
Published: August 2025
|
Delivery: Immediate
Download Sample
Customisation Request
Revenue,
USD 19.98 Bn
Forecast Year,
USD 47.79 Bn
CAGR, 2025 -
9.11%
Report Coverage
Worldwide
Reviewed By
Aditi Shivarkar
Reviewed By
Aman Singh
Seasonal Influenza Vaccines and Therapeutics Market Size Analysis
Seasonal Influenza Vaccines and Therapeutics Market Size By Therapy & Class 2024 to 2034 (USD )
| Therapy & Class | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Small Molecules | 6.39 | 6.96 | 7.53 | 8.25 | 8.98 | 9.76 | 10.69 | 11.65 | 12.78 | 14.00 | 15.34 |
| Biologics | 6.79 | 7.42 | 8.10 | 8.82 | 9.64 | 10.58 | 11.55 | 12.56 | 13.68 | 14.84 | 16.18 |
| Advanced Therapies | 3.60 | 3.93 | 4.34 | 4.74 | 5.17 | 5.60 | 6.07 | 6.66 | 7.27 | 7.95 | 8.64 |
| Others | 3.20 | 3.49 | 3.81 | 4.15 | 4.53 | 4.96 | 5.41 | 5.92 | 6.41 | 7.01 | 7.63 |
Seasonal Influenza Vaccines and Therapeutics Market Size By Indication 2024 to 2034 (USD )
| Indication | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oncology | 7.19 | 7.85 | 8.60 | 9.44 | 10.33 | 11.28 | 12.32 | 13.35 | 14.49 | 15.89 | 17.31 |
| Cardio-Metabolic | 3.60 | 3.93 | 4.30 | 4.67 | 5.09 | 5.58 | 6.09 | 6.64 | 7.27 | 7.92 | 8.64 |
| Infectious | 3.20 | 3.48 | 3.79 | 4.14 | 4.50 | 4.92 | 5.37 | 5.90 | 6.47 | 7.04 | 7.73 |
| CNS | 2.80 | 3.05 | 3.31 | 3.58 | 3.93 | 4.25 | 4.64 | 5.11 | 5.58 | 6.06 | 6.58 |
| Others | 3.20 | 3.49 | 3.79 | 4.13 | 4.46 | 4.87 | 5.29 | 5.79 | 6.33 | 6.88 | 7.52 |
Seasonal Influenza Vaccines and Therapeutics Market Size By Distribution 2024 to 2034 (USD )
| Distribution | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Hospital Pharmacy | 8.79 | 9.60 | 10.47 | 11.44 | 12.50 | 13.66 | 14.85 | 16.20 | 17.80 | 19.40 | 21.13 |
| Retail Pharmacy | 7.19 | 7.84 | 8.59 | 9.33 | 10.16 | 11.03 | 12.09 | 13.21 | 14.34 | 15.64 | 17.12 |
| Online/Other | 4.00 | 4.36 | 4.72 | 5.19 | 5.66 | 6.20 | 6.78 | 7.38 | 8.00 | 8.76 | 9.54 |
Seasonal Influenza Vaccines and Therapeutics Market Size By Region 2024 to 2034 (USD )
| Region | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| North America | 7.99 | 8.74 | 9.58 | 10.41 | 11.37 | 12.33 | 13.47 | 14.68 | 16.02 | 17.50 | 19.16 |
| Europe | 5.59 | 6.09 | 6.61 | 7.21 | 7.86 | 8.64 | 9.42 | 10.26 | 11.23 | 12.17 | 13.26 |
| Asia Pacific | 4.79 | 5.22 | 5.70 | 6.25 | 6.80 | 7.42 | 8.11 | 8.89 | 9.66 | 10.58 | 11.50 |
| Latin America | 0.80 | 0.88 | 0.95 | 1.04 | 1.14 | 1.24 | 1.35 | 1.48 | 1.61 | 1.77 | 1.92 |
| Middle East & Africa | 0.80 | 0.87 | 0.95 | 1.05 | 1.14 | 1.26 | 1.37 | 1.48 | 1.63 | 1.79 | 1.94 |
Seasonal Influenza Vaccines and Therapeutics Market
Seasonal Influenza Vaccines and Therapeutics Market
Proceed To Buy
Proceed To CheckoutMake Every Move Strategic. Get Insights, Fully Customized
- On-Demand Metrics & KPIs
- Industry-Specific Dashboards
- Quick Turnaround, No Compromises
Quick Contact
- NA : +1 804 441 9344
- APAC : +91 9356 9282 04
- EU : +44 7782 560 738
- sales@precedenceresearch.com
